Skip to search formSkip to main contentSkip to account menu

oxovanadium IV

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
The inhibitory effects of three biguanido–oxovanadium complexes ([VO(L1−3)2]·nH2O: HL1 = metformin, HL2 = phenformin, HL3… 
Highly Cited
2009
Highly Cited
2009
The hydrothermal reactions of NH4VO3 with the aromatic phosphonate ligands 1,4-, 1,3-, and 1,2-phenylenediphosphonic acids (H4L1… 
Highly Cited
2006
Highly Cited
2006
The oxovanadium(IV)-lanthanide(III) heteronuclear complexes, [[Ce(H2O)7(VO)(TTHA)0.5][(VO)2(TTHA)]].8H2O (2), [Pr(H2O)7(VO)3(TTHA… 
2006
2006
A stable organic sol of solvent-stabilized oxovanadium phthalocynine (VOPc) nanoparticles with excellent photoconductivity was… 
2004
2004
Though vanadium complexes mimic the action of insulin, owing to their toxicity, research is still in progress for a new vanadium… 
Review
2004
Review
2004
Recently, Poucheret et al. [1] reviewed some key aspects of vanadium in relation to its insulin-mimetic, antihyperglycemic and… 
2002
2002
Oxovanadium complexes with H(2)bzimpy (2,6-bis[benzimidazol-2'-yl]pyridine) and Me(2)bzimpy (2,6-bis[N'-methylbenzimidazol-2'-yl… 
Highly Cited
2001
Highly Cited
2001
The hydrothermal reactions of CuCl2*2H2O, Na3VO4, 1,10-phenanthroline, and the appropriate organodiphosphonate ligand yield [Cu…